(Q38372837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

1 reference

title

Efficacy of extracorporeal ultrasound-guided high intensity focused ultrasound: An evaluation based on controlled trials in China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Jun Luo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Xueyi Ren

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

28 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Biology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

480-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25758333%20AND%20SRC:MED&resulttype=core&format=json

High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas.

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Pancreatic cancer: why is it so hard to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

High intensity focused ultrasound ablation: a new therapeutic option for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Natural history of early, localized prostate cancer: a final report from three decades of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Chemoembolization in the Management of Liver Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

The feasibility and safety of high-intensity focused ultrasound combined with low-dose external beam radiotherapy as supplemental therapy for advanced prostate cancer following hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Ultrasonic therapy for gynecologic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962

High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2015.1021962